［1］Garrod AE. The incidence of alkaptonuria: a study in chemical individuality［J］. Lancet, 1902, 160(4137): 1616,1620.
［2］Garrod AE. The Croonian lectures on inborn errors of metabolism, lecture II: alkaptonuria［J］. Lancet, 1908, 172: 73,79.
［3］Pandey R, Kumar A , Garg R, Khanna P, Darlong V. Perioperative management of patient with alkaptonuria and associated multiple comorbiditie［J］. J Anaesthesiol Clin Pharmaco, 2011, 27(2): 259,261.
［4］Vinjamuri S, Ramesh CN, Jarvis J, Gallagher JA, Ranganath LL. Nuclear medicine techniques in the assessment of alkaptonuria［J］. Nucl Med Commun, 2011, 32(10): 880,886.
［5］Zatkova A. An update on molecular genetics of Alkaptonuria(AKU)［J］. J Inherit Metab Dis, 2011, 34(6): 1127,1136.
［11］Tharini G, Ravindran V, Hema N, Prabhavathy D, Parveen B. Alkaptonuria［J］. Indian J Dermatol, 2011, 56(2): 194,196.
［12］Wolff JA, Barshop B, Nyhan WL, Leslie J, Seegmiller JE, Gruber H, et al. Effects of ascorbic acid in alkaptonuria: alterations in benzoquinone acetic acid and an ontogenic effect in infancy［J］. Pediatr Res, 1989, 26(2): 140,144.
［13］Morava E, Kosztolanyi G, Engelke UF, Wevers RA. Reversal of clinical symptoms and radiographic abnormalities with protein restriction and ascorbic acid in alkaptonuria［J］. Ann Clin Biochem, 2003, 40(Pt 1): 108-111.
［14］Anikster Y, Nyhan WL, Gahl WA. NTBC and alkaptonuria［J］. Am J Hum Genet, 1998, 63(3): 920-921.
［15］Introne WJ, Perry MB, Troendle J, Tsilou E, Kayser MA, Suwannarat P, et al. A 3-year randomized therapeutic trial of nitisinone in alkaptonuria［J］. Mol Genet Metab, 2011, 103(4): 307-314.
